Clinical Research

Eli Lilly Reveals Promising Phase 3 Results for Lebrikizumab in Patients with Skin of Color

Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color...

 March 11, 2024 | News

TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA

TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...

 March 11, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

 March 06, 2024 | News

Innovent Biologics and AnHeart Therapeutics Secure Second NDA Acceptance for Groundbreaking Lung Cancer Treatment in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

 March 06, 2024 | News

Caliway's CBL-514 Gains FDA Orphan Drug and Fast Track Designations for Dercum's Disease Treatment

Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to CBL-514 for Dercum...

 March 05, 2024 | News

Suven Pharmaceuticals Joins Forces with Cohance Lifesciences in Transformative Merger to Strengthen CDMO Dominance

  Transformative Merger with 2x Scale and Double-Digit EPS Accretion in the first year Suven poised to become a leading integrated CDMO player...

 March 01, 2024 | News

Medidata and Sanofi Boost Trial Efficiency with Expanded Patient-Centric Collaboration

 Medidata, a Dassault Systèmes subsidiary and a leading provider of clinical trial solutions for the life sciences industry, today announced a ...

 February 29, 2024 | News

Emmes Endpoints Solutions Advances Duchenne Muscular Dystrophy Research with Innovative FDA Submission

    The DVA is designed to assess the progression and severity of DMD through videos of patients performing functional tasks at home, eliminati...

 February 28, 2024 | News

Neomorph, Novo Nordisk Partner on Molecular Glue Degraders for Diseases

Collaboration leverages Neomorph's leading molecular glue discovery platform and Novo Nordisk's extensive expertise in cardiometabolic and rare diseases ...

 March 27, 2024 | News

Oscotec/ ADEL Launch First Human Trial for Novel Alzheimer's Treatment ADEL-Y01

  In a significant stride towards Alzheimer's disease (AD) treatment, Oscotec Inc. in collaboration with ADEL Inc., has announced the initiation of f...

 February 26, 2024 | News

Immunofoco Achieves Historic Dual IND Approval for Groundbreaking EpCAM CAR-T Therapy

  EpCAM, known for its presence in circulating tumor cells (CTCs) and high expression in primary and metastatic lesions of gastrointestinal tumors, r...

 February 26, 2024 | News

CATUG and Crystal Bio Launch Joint Lab for Advanced Nucleic Acid Analysis

CATUG, a distinguished global entity specializing in integrated nucleic acid and drug delivery CRDMO services, is combining capabilities with Crystal ...

 February 25, 2024 | News

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...

 February 23, 2024 | News

RSSL Launches Innovation Hub for Biotech Support with Labs and Services

  RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a wide range of tailored services to help t...

 February 22, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close